Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published online as doi:10.1189/jlb.1106660 on January 22, 2007

Published online before print January 22, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
jlb.1106660v1
81/4/1002    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baba, M.
Right arrow Articles by Kawasaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baba, M.
Right arrow Articles by Kawasaki, T.
(Journal of Leukocyte Biology. 2007;81:1002-1011.)
© 2007 by Society for Leukocyte Biology

Glycosylation-dependent interaction of Jacalin with CD45 induces T lymphocyte activation and Th1/Th2 cytokine secretion

Makoto Baba*,{dagger},1, Bruce Yong Ma*,1,2, Motohiro Nonaka*,{dagger}, Yukari Matsuishi{ddagger}, Makoto Hirano*,{dagger}, Natsuko Nakamura*,{dagger}, Nana Kawasaki{ddagger}, Nobuko Kawasaki* and Toshisuke Kawasaki*,2

* Research Center for Glycobiotechnology, Ritsumeikan University, Shiga, Japan;
{dagger} Department of Biological Chemistry, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan; and
{ddagger} Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Tokyo, Japan

2 Correspondence: Research Center for Glycobiotechnology, Ritsumeikan University, Shiga 525-8577, Japan. E-mail: byma{at}fc.ritsumei.ac.jp; tkawasaki{at}fc.ritsumei.ac.jp

Jacalin, an {alpha}-O-glycoside of the disaccharide Thomsen-Friedenreich antigen (galactose ß1-3 N-acetylgalactosamine, T-antigen)-specific lectin from jackfruit seeds, has been shown to induce mitogenic responses and to block infection by HIV-1 in CD4+ T lymphocytes. The molecular mechanism underlying Jacalin-induced T cell activation has not been elucidated completely yet. In the present study, protein tyrosine phosphatase (PTPase) CD45 was isolated from a Jurkat T cell membrane fraction as a major receptor for Jacalin through affinity chromatography and mass spectrometry. CD45, which is highly glycosylated and expressed exclusively on the surface of lymphocytes, is a key regulator of lymphocyte signaling, playing a pivotal role in activation and development. We found that the lectin induced significant IL-2 production by a CD45-positive Jurkat T cell line (JE6.1) and primary T cells. However, this effect did not occur in a CD45-negative Jurkat T cell line (J45.01) and was blocked completely by a specific CD45 PTPase inhibitor in Jurkat T (JE6.1) and primary T cells. Furthermore, we also observed that Jacalin caused a marked increase in IL-2 secretion in response to TCR ligation and CD28 costimulation and contributed to Th1/Th2 cytokine production by activating CD45. Jacalin increased CD45 tyrosine phosphatase activity, which resulted in activation of the ERK1/2 and p38 MAPK cascades. Based on these findings, we propose a new, immunoregulatory model for Jacalin, wherein glycosylation-dependent interactions of Jacalin with CD45 on T cells elevate TCR-mediated signaling, which thereby up-regulate T cell activation thresholds and Th1/Th2 cytokine secretion.

Key Words: carbohydrate recognition • lectin-carbohydrate interaction • protein-tyrosine phosphatases • protein-tyrosine kinase






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Leukocyte Biology.